Unknown OBSERVATIONAL NCT04734769

Embryos With Preimplantation Genetic Testing for Aneuploidies (PGT-A) Inconclusive Result: Clinical Implications

Sponsor: IVI Vigo

Interventions Collect retrospectively clinical data on reproductive outcomes

Updated 5 times since 2021 Last updated: Feb 1, 2021 Started: Feb 20, 2021 Primary completion: Feb 21, 2021 Completion: Nov 25, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Embryo Disorder, this trial is ongoing. The trial is conducted by IVI Vigo and has accumulated 5 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Nov 2023 — Jul 2024 [monthly]

Unknown Status
Feb 2023 — Nov 2023 [monthly]

Unknown Status

Status: Not Yet Recruiting → Unknown Status
Mar 2021 — Feb 2023 [monthly]

Not Yet Recruiting

First recorded

Feb 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

IVI Vigo
Instituto Valenciano de Infertilidad, IVI VALENCIA
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Data source: IVI Vigo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.